Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 2-(pyrazin-2-ylcarbonylaminomethyl) benzimidazolium compounds as epithelial sodium channel inhibitors

2-(pyrazin-2-ylcarbonylaminomethyl) benzimidazolium compounds as epithelial sodium channel inhibitors

US Patent 9981954 · Granted May 29, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pyridine derivatives with n-linked cyclic substituents as cGAS inhibitors2025
Cyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamide2025
CCR2 receptor antagonists and uses thereof2025
Lubricating compositions with decarboxylated rosin acid2024
Pyridine derivatives with c-linked cyclic substituents as cGAS inhibitors2024
CCR2 receptor antagonists and uses thereof2023
Cyclic ether derivatives of pyrazolo[1,5-A]pyrimidine-3-carboxyamide2023
Triazole benzamide derivatives as GPR142 agonists2021
Triazole benzamide derivatives as GPR142 agonists2021
CCR2 receptor antagonists and uses thereof2021
Cyclic ether derivatives of pyrazolo[1,5-a]pyrimidine-3-carboxyamide2020
Sulfonamides as inhibitors of the uptake of extracellular citrate2020